05/27/2020
8:29 AM | AcelRx Pharmaceuticals (Subject)
TETRAPHASE PHARMACEUTICALS INC (Filed by)
| Form 425
| |
05/22/2020
3:11 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2020
3:10 PM | AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
| Form 425
| |
04/30/2020
7:24 AM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2020
7:22 AM | AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
| Form 425
| |
04/26/2020
11:15 PM | AcelRx Pharmaceuticals (Filer)
| Form EFFECT
| |
04/24/2020
5:09 AM | AcelRx Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020
5:07 AM | AcelRx Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/17/2020
3:52 PM | AcelRx Pharmaceuticals (Filer)
| Form 10-K/A
| |
04/08/2020
3:05 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/06/2020
4:24 PM | AcelRx Pharmaceuticals (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
03/25/2020
3:01 PM | AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
| Form 425
| |
03/16/2020
2:57 PM | AcelRx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/16/2020
2:24 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/16/2020
2:22 PM | AcelRx Pharmaceuticals (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
| Form 425
| |
03/16/2020
6:40 AM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2020
8:13 PM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
8:12 PM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
8:10 PM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
8:09 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
8:08 PM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
6:06 AM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
5:07 AM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
3:26 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2019
5:07 AM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
5:05 AM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
5:05 AM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
5:05 AM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
5:04 AM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2019
3:05 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2019
3:52 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
3:10 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2019
6:05 PM | AcelRx Pharmaceuticals (Issuer)
WAN MARK A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
6:04 PM | AcelRx Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
6:03 PM | AcelRx Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
6:02 PM | AcelRx Pharmaceuticals (Issuer)
Afable Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
6:00 PM | AcelRx Pharmaceuticals (Issuer)
ADAMS ADRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
5:58 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:49 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2019
5:02 AM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
6:10 AM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2019
5:08 AM | AcelRx Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/14/2019
5:03 AM | AcelRx Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/09/2019
7:55 AM | AcelRx Pharmaceuticals (Filer)
| Form 424B5
| |
05/09/2019
7:52 AM | AcelRx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
3:04 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2019
4:03 PM | AcelRx Pharmaceuticals (Filer)
| Form PRE 14A
| |
04/30/2019
5:20 AM | AcelRx Pharmaceuticals (Filer)
| Form 10-K/A
| |
03/12/2019
1:15 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
4:29 PM | AcelRx Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2019
4:25 PM | AcelRx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2019
3:05 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
3:28 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
3:26 PM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:45 PM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:44 PM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:43 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:42 PM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
4:40 PM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2019
4:33 PM | AcelRx Pharmaceuticals (Issuer)
HOFFMAN STEPHEN J (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/11/2019
3:31 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
11:05 AM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2018
11:04 AM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
6:31 PM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2018
5:13 PM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
5:35 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2018
4:18 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
4:16 PM | AcelRx Pharmaceuticals (Filer)
| Form 424B5
| |
11/13/2018
12:53 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
6:06 AM | AcelRx Pharmaceuticals (Filer)
| Form 424B5
| |
11/05/2018
4:29 PM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
4:24 PM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
4:23 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
4:21 PM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
3:50 PM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
8:23 AM | AcelRx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2018
3:14 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2018
2:05 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2018
3:30 PM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2018
3:29 PM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2018
4:54 PM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
5:08 AM | AcelRx Pharmaceuticals (Issuer)
Dasu Badri N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
5:06 AM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
5:06 AM | AcelRx Pharmaceuticals (Issuer)
Angotti Vincent J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
5:06 AM | AcelRx Pharmaceuticals (Issuer)
Hamel Lawrence G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
3:36 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2018
4:38 PM | AcelRx Pharmaceuticals (Issuer)
Palmer Pamela P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2018
4:23 PM | AcelRx Pharmaceuticals (Issuer)
ASADORIAN RAFFI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
4:19 PM | AcelRx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2018
3:18 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2018
3:16 PM | AcelRx Pharmaceuticals (Filer)
| Form 424B5
| |
07/02/2018
3:51 PM | AcelRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2018
5:19 PM | AcelRx Pharmaceuticals (Issuer)
ADAMS ADRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
5:18 PM | AcelRx Pharmaceuticals (Issuer)
Afable Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
5:16 PM | AcelRx Pharmaceuticals (Issuer)
HOFFMAN C STEVEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
5:14 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
5:13 PM | AcelRx Pharmaceuticals (Issuer)
Rosen Howard B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
5:12 PM | AcelRx Pharmaceuticals (Issuer)
WAN MARK A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2018
4:52 PM | AcelRx Pharmaceuticals (Issuer)
EDWARDS MARK G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2018
10:17 AM | AcelRx Pharmaceuticals (Subject)
LEERINK REVELATION HEALTHCARE FUND I, L.P. (Filed by)
| Form SC 13G
| |
